PEOPLE ON THE MOVE
Bristol-Myers Squibb CEO to transition to Chairman of Board
Giovanni Carforio will start as Chairman to the board of directors at BMS, whilst continuing to serve as Chief executive officer until the annual meeting of shareholders on May.
Carforio stepped into the CEO role last May for BMS, which has a focus on Immuno-Oncology. He has also served on the biopharmaceutical firm’s board of Directors since June 2014.
Hailing from Rome, Carforio has previously held other positions at BMS, including as Chief Operating Officer for worldwide commercialization and companywide Enterprise Services and Global Manufacturing & Supply, and as Chief Commercial Officer.